Cargando…

Tissue expression of PD-L1 mediates peripheral T cell tolerance

Programmed death 1 (PD-1), an inhibitory receptor expressed on activated lymphocytes, regulates tolerance and autoimmunity. PD-1 has two ligands: PD-1 ligand 1 (PD-L1), which is expressed broadly on hematopoietic and parenchymal cells, including pancreatic islet cells; and PD-L2, which is restricted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keir, Mary E., Liang, Spencer C., Guleria, Indira, Latchman, Yvette E., Qipo, Andi, Albacker, Lee A., Koulmanda, Maria, Freeman, Gordon J., Sayegh, Mohamed H., Sharpe, Arlene H.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118286/ https://www.ncbi.nlm.nih.gov/pubmed/16606670 http://dx.doi.org/10.1084/jem.20051776

Ejemplares similares

Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
por: Freeman, Gordon J., et al.
Publicado: (2006)

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
por: Xiao, Yanping, et al.
Publicado: (2014)

The Role of TNF-α in Mice with Type 1- and 2- Diabetes
por: Koulmanda, Maria, et al.
Publicado: (2012)

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
por: Rice, Adrian E, et al.
Publicado: (2015)

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
por: Fife, Brian T., et al.
Publicado: (2006)

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
por: Francisco, Loise M., et al.
Publicado: (2009)

Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection
por: Ha, Sang-Jun, et al.
Publicado: (2008)

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
por: Tan, Catherine L., et al.
Publicado: (2020)

PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability
por: Hurrell, Benjamin P., et al.
Publicado: (2022)

Creating transplant tolerance by taming adverse intragraft innate immunity
por: Hanidziar, Dusan, et al.
Publicado: (2010)

A critical role for the programmed death ligand 1 in fetomaternal tolerance
por: Guleria, Indira, et al.
Publicado: (2005)

CD28 Costimulation Regulates Genome-Wide Effects on Alternative Splicing
por: Butte, Manish J., et al.
Publicado: (2012)

Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes
por: Kochupurakkal, Nora M., et al.
Publicado: (2014)

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
por: Juneja, Vikram R., et al.
Publicado: (2017)

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses
por: Bu, Xia, et al.
Publicado: (2021)

Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses
por: Mott, Kevin R., et al.
Publicado: (2014)

Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanisms
por: Borges, Thiago J., et al.
Publicado: (2021)

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
por: Good-Jacobson, Kim L., et al.
Publicado: (2010)

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8(+) T cells
por: Odorizzi, Pamela M., et al.
Publicado: (2015)

Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection
por: Penaloza-MacMaster, Pablo, et al.
Publicado: (2014)

Peripheral tolerance induced by apoptotic cells and PD-1+ CD8 T cells
por: Kazama, Hirotaka, et al.
Publicado: (2012)

PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
por: Helou, Doumet Georges, et al.
Publicado: (2020)

Podocyturia as a Diagnostic Marker for Preeclampsia amongst High-Risk Pregnant Patients
por: Jim, Belinda, et al.
Publicado: (2012)

Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy
por: Ebot, Ericka M., et al.
Publicado: (2022)

A Comparison of Podocyturia, Albuminuria and Nephrinuria in Predicting the Development of Preeclampsia: A Prospective Study
por: Jim, Belinda, et al.
Publicado: (2014)

Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005)

A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies
por: Bu, Melissa T., et al.
Publicado: (2022)

Alpha‐1‐antitrypsin in cell and organ transplantation
por: Berger, Mel, et al.
Publicado: (2018)

PD-L1 – PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection
por: Perry, Joseph A., et al.
Publicado: (2022)

Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection
por: Maazi, Hadi, et al.
Publicado: (2013)

Clonal dynamics of alloreactive T cells in kidney allograft rejection after anti-PD-1 therapy
por: Dunlap, Garrett S., et al.
Publicado: (2023)

PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease
por: Policheni, Antonia N., et al.
Publicado: (2022)

Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study
por: Jim, Belinda, et al.
Publicado: (2012)

CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
por: Sakai, Shunsuke, et al.
Publicado: (2016)

Core skin DC signatures control immune tolerance to skin cancer and limit anti-tumor immunity
por: Nirschl, Christopher, et al.
Publicado: (2015)

Do heat shock proteins have a role in breast cancer?
por: Conroy, S. E., et al.
Publicado: (1996)

Measuring Peripheral Chemoreflex Hypersensitivity in Heart Failure
por: Keir, Daniel A., et al.
Publicado: (2020)

Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response
por: Kelly, Andrew D, et al.
Publicado: (2021)

PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma
por: Howard, Emily, et al.
Publicado: (2021)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jso52oguga433mhk6f3vqlr3b1